Agenus Inc. (AGEN)
NASDAQ: AGEN · Real-Time Price · USD
6.13
-0.03 (-0.49%)
Oct 27, 2026, 10:12 AM EDT - Market open
Agenus Market Cap
Agenus has a market cap or net worth of $275.98 million as of October 27, 2026. It is the 18,622nd most valuable company in the world and the 3,270th biggest in the United States. Its market cap has increased by 113.93% in one year.
Market Cap
275.98M
Enterprise Value
297.95M
1-Year Change
113.93%
Global Rank
Country Rank
#3,270 United States
Category
ChartMarket Cap Chart
Since February 8, 2000, Agenus's market cap has decreased from $1.10B to $275.98M, a decrease of -74.84%. That is a compound annual growth rate of -5.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 285.00M | 166.85% |
| Dec 31, 2025 | 106.80M | 66.10% |
| Dec 31, 2024 | 64.30M | -79.64% |
| Dec 29, 2023 | 315.80M | -56.83% |
| Dec 30, 2022 | 731.50M | -11.55% |
| Dec 31, 2021 | 827.00M | 36.76% |
| Dec 31, 2020 | 604.70M | 8.16% |
| Dec 31, 2019 | 559.10M | 95.76% |
| Dec 31, 2018 | 285.60M | -12.55% |
| Dec 29, 2017 | 326.60M | -9.03% |
| Dec 30, 2016 | 359.00M | -6.58% |
| Dec 31, 2015 | 384.30M | 54.40% |
| Dec 31, 2014 | 248.90M | 165.92% |
| Dec 31, 2013 | 93.60M | -7.14% |
| Dec 31, 2012 | 100.80M | 134.97% |
| Dec 30, 2011 | 42.90M | -57.23% |
| Dec 31, 2010 | 100.30M | 74.74% |
| Dec 31, 2009 | 57.40M | 80.50% |
| Dec 31, 2008 | 31.80M | -67.22% |
| Dec 31, 2007 | 97.00M | 15.61% |
| Dec 29, 2006 | 83.90M | -61.34% |
| Dec 30, 2005 | 217.00M | -52.90% |
| Dec 31, 2004 | 460.70M | 2.90% |
| Dec 31, 2003 | 447.70M | 32.18% |
| Dec 31, 2002 | 338.70M | -28.80% |
View and export this data all the way back to 2000. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Eikon Therapeutics | 300.07M |
| Benitec Biopharma | 299.64M |
| Scribe Therapeutics | 295.33M |
| Arcturus Therapeutics Holdings | 281.67M |
| Fulcrum Therapeutics | 277.72M |
| Inhibikase Therapeutics | 276.75M |
| Opus Genetics | 276.21M |
| Alector | 271.31M |